Align Technology (NASDAQ:ALGN – Get Free Report) announced its earnings results on Wednesday. The medical equipment provider reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.04, Briefing.com reports. The business had revenue of $977.87 million during the quarter, compared to analysts’ expectations of $990.05 million. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. The company’s quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted $1.62 earnings per share. Align Technology updated its Q4 2024 guidance to EPS.
Align Technology Stock Performance
Align Technology stock opened at $216.42 on Friday. The firm’s 50 day moving average price is $234.20 and its two-hundred day moving average price is $250.96. The firm has a market cap of $16.29 billion, a PE ratio of 35.65, a P/E/G ratio of 5.33 and a beta of 1.64. Align Technology has a twelve month low of $176.34 and a twelve month high of $335.40.
Insider Activity
In other news, Director C Raymond Larkin, Jr. acquired 6,500 shares of Align Technology stock in a transaction that occurred on Thursday, August 15th. The stock was purchased at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now owns 28,247 shares in the company, valued at approximately $6,647,366.51. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Report on Align Technology
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
See Also
- Five stocks we like better than Align Technology
- How to Calculate Stock Profit
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- 3 Tickers Leading a Meme Stock Revival
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- What is the Shanghai Stock Exchange Composite Index?
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.